MET and hepatocellular carcinoma: Human MET overexpression in mouse liver produced a gene signature, prior to the appearance of tumors, that was significantly enriched in the human AN-survival genes, in genes that participate in human HCC network changes, and in genes associated in human HCC with sCNV.